UQ spin-off company to develop precision painkillers for treating debilitating conditions

3D render of a medical background with DNA strands

Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company -; potentially changing the lives of millions of people.

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Previous article

Circadian disruption induces weight gain through changes in gut microbiota

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News